Submit Deal

Thomas Schinecker

CEO at ROCHE HOLDINGS AG

Manager

Deal Bio

Total Deals8

Valued Deals5

Total Value£10,909M

Avg. Deal Size£2,182M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (8)

Sort

United States

Biotechnology

MajorityAcquisitionPrivate

target

Stratos Genomics

bidder

Roche Holdings

value n/a

3 dealmakers

Denmark

Software

Cross BorderMajorityPrivateAcquisition

target

Obi Medical Aps

bidder

Roche Holdings

value n/a

14 dealmakers

United States

Medical Services

AcquisitionPublicTender OfferMajorityCross Border

target

Genmark Diagnostics

bidder

Roche Holdings

£1,292m

33 dealmakers

Germany

Biotechnology

AcquisitionPrivateCross BorderMajority

target

Tib Molbiol

bidder

Roche Holdings

value n/a

41 dealmakers

United States

Biotechnology

AcquisitionDomesticPrivateMajority

target

Telavant Holdings

bidder

Roche Holdings

£5,960m

32 dealmakers

United States

Biotechnology

Cross BorderPrivateAcquisitionMajority

target

Carmot Therapeutics

bidder

Roche Holdings

£2,438m

49 dealmakers

United Kingdom

Medical Equipment

AcquisitionMajorityCross BorderPrivate

target

Lumiradx (point Of Care Technology Platform)

bidder

Roche Holdings

£273m

12 dealmakers

United States

Pharmaceuticals

AcquisitionCross BorderMajorityPrivateInfrastructure

target

Roche Holdings (genentech Large-scale Biologics Manufacturing Site)

bidder

Lonza Group

£944m

4 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy